1. Home
  2. All topics: A to Z
  3. Invasive pneumococcal disease

Invasive pneumococcal disease

Disease data from ECDC Surveillance Atlas

Get the latest surveillance data on invasive pneumococcal disease from EU and EEA countries through the Surveillance Atlas of Infectious Diseases.

Get the data

Disease facts

Pneumococcal diseases are symptomatic infections caused by the bacterium Streptococcus pneumoniae

Read the factsheet

Latest updates

Publication

External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019

External quality assessment -

Publication

Invasive pneumococcal disease - Annual Epidemiological Report for 2018

Surveillance report -

Peer-Reviewed Publication

A cluster of Legionnaires' disease in Belgium linked to a cooling tower, August-September 2016: Practical approach and challenges

Dec 2019

Data

Surveillance systems overview for 2018

Table -

Publication

External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019

External quality assessment -

Publication

Invasive pneumococcal disease - Annual Epidemiological Report for 2018

Surveillance report -

Peer-Reviewed Publication

A cluster of Legionnaires' disease in Belgium linked to a cooling tower, August-September 2016: Practical approach and challenges

Dec 2019

Publication

Invasive pneumococcal disease - Annual Epidemiological Report for 2017

Surveillance report -

News

Effect of introducing high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children

News -

News

Decline in early childhood respiratory tract infections in the norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccinationArchived

ECDC comment -

News

A review of the effect of immunization programs on antimicrobial utilizationArchived

ECDC comment -

News

Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in childrenArchived

ECDC comment -
There are currently no items to display

Data

Surveillance systems overview for 2018

Table -

Data

Surveillance systems overview for 2017

Table -

Data

Surveillance systems overview for 2016

Table -

Data

Surveillance systems overview for 2015

Table -

Scientific advice

Policy briefings, guidance, expert opinions, risk assessments and peer-reviewed publications

Surveillance and disease data

Microbiology

ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods.

Prevention and control

Childhood immunisation against S. pneumoniae is the most effective public health measure for preventing IPD both among vaccine recipients (direct effect), and among unimmunised populations (indirect ‘herd’ effect).

Facts

Despite good access to effective antibiotics, Streptococcus pneumoniae (pneumococci) is still a major cause of disease and death in both developing and developed countries.

Featured content

Related content

Vaccine-preventable diseases

2009 influenza A (H1N1) pandemic

Disease / public health area

Cholera

Disease / public health area

Congenital rubella syndrome (CRS)

Disease / public health area

Diphtheria

Disease / public health area

Hepatitis B

Disease programmes and networks

European Invasive Bacterial Disease Surveillance Network (EU-IBD)